William V. La Via

Clinical Profile of Pediatric Patients Hospitalized With Respiratory Syncytial Virus Infection

William V. La Via, Steven W. Grant, Harris R. Stutman et al. · Clinical Pediatrics · 1993 · 48 citations

Asthma, Pediatric Heart Disease, Respiratory Complications +16

Three monthly doses of palivizumab are not adequate for 5-month protection: A population pharmacokinetic analysis

William V. La Via, Gerard Notario, Xiang‐Qing Yu et al. · Pulmonary Pharmacology & Therapeutics · 2013 · 30 citations · Full text

Asthma, Pediatric Lung Disease, Population Pharmacokinetic Analysis +17

Evaluation of persistent pulmonary infiltrates in pediatric oncology patients

Saro H. Armenian, William V. La Via, Stuart E. Siegel et al. · Pediatric Blood & Cancer · 2006 · 26 citations

Medically Attended Illness due to Respiratory Syncytial Virus Infection Among Infants Born in the United States Between 2016 and 2020

Jason R. Gantenberg, Robertus van Aalst, Nicole M. Zimmerman et al. · The Journal of Infectious Diseases · 2022 · 21 citations · Full text

Measurement of Amphotericin B concentration by Resonant Raman Spectroscopy – a novel technique that may be useful for non-invasive monitoring

William V. La Via, James L. Lambert, M. J. Pelletier et al. · Medical Mycology · 2006 · 15 citations · Full text

Amphotericin B Concentration, Surface-enhanced Raman Scattering, Analytical Instrumentation +21